prostate cancer | Clinical Trial | Added Mar 28, 2019
Searching for patients with stage 3-4 prostate cancer to test a treatment combination.
This trial is examining the effectiveness of radiation therapy with or without apalutamide (Erleada) in the treatment of stage 3-4 prostate cancer. The main outcome to be measured will be survival without cancer worsening. This trial is recruiting in Canada and the United States.
prostate cancer | Research | 10 pages | source: European Urology | Added Mar 26, 2019
How long should hormonal therapy continue in patients who have received postprostatectomy radiotherapy?
This study examined how long hormonal therapy should continue in patients who have received radiotherapy after prostate removal surgery (prostatectomy). This study concluded that patients with a higher number of risk risk factors should receive HT for a longer period of time.
prostate cancer | Clinical Trial | Added Mar 16, 2019
Searching for patients with advanced prostate cancer to test a new drug combination
This phase 3 trial will evaluate the safety and effectiveness of olaparib (Lynparza) and abiraterone (Zytiga) combination in prostate cancer.
The main outcome will be the rate of survival without cancer growing or spreading.
nocturia | Research | Lifestyle | 10 pages | source: Neurourology and urodynamics | Added Feb 28, 2019
Does reducing salt intake improve nocturia in patients with excessive salt intake?
This study aimed to investigate the link between salt intake and nocturia. This study found that reducing salt intake had beneficial effects on nocturia symptoms.
prostate cancer | Research | Treatment | 10 pages | source: World Journal of Urology | Added Feb 24, 2019
Combined radiation therapy used to treat unfavorable-risk prostate cancer
This study aimed to investigate the use of combined-modality radiation treatment (CRT) in the treatment of prostate cancer (PCa). This study found that CRT is an effective treatment for PCa.
prostate cancer | Clinical Trial | Added Jan 20, 2019
Looking for men with prostate cancer, resistant to male hormone suppression, to be treated with medication and radiotherapy
This study evaluates the effectiveness of medication and focal radiation in the treatment of prostate cancer resistant male hormone suppression. The main outcome to be measured in this trial is the number of patients whose cancer does not grow or spread and who are alive at 18 months after treatment. This trial is taking place in Ann Arbor, Michigan, United States.
prostate cancer | Clinical Trial | Added Dec 10, 2018
Searching for patients with castration resistant metastatic prostate cancer to test cabazitaxel and abiraterone
This trial is examining the safety and effectiveness of cabazitaxel (Jevtana) with abiraterone acetate (Zytiga) compared to abiraterone acetate alone for metastatic (cancer that has spread) castration-resistant prostate cancer (cancer that is no longer responding to hormone therapy). The main outcome measured will be the progression-free survival (the time that the disease does not get worse).
prostate cancer | Medivizor | source: Medivizor | Added Dec 02, 2018
Oncology Basics 2016
"Nixon asked, 'Doctor, what do you consider the most pressing problem that medicine has today?'...My answer was simple: 'Cancer.' He said, 'I'm amazed. Why do you say that?' My reply was, 'I think every physician who is dedicated and sincere never goes on the floor of a hospital where he has cancer patients...-without feeling helpless.nocturia | Research | 10 pages | source: International journal of clinical practice | Added Dec 01, 2018
Is nocturia more bothersome than daytime urinary symptoms?
This study examined the differences in quality of life for patients with nocturia compared to those with daytime urinary symptoms only. This study found that patients with nocturia had a lower quality of life than patients with daytime symptoms only.
prostate cancer | Medivizor | source: Medivizor | Added Nov 30, 2018
Cancer Vaccines
When I think of vaccines, I think of the MMRV (measles, mumps, rubella and varicella) vaccines which help our bodies establish immunity against diseases that used to kill. Now, there are vaccines being created for cancer. The rise of cancer vaccines According to Dr. Nora Disis, an oncologist and researcher
